Virbac Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:Virbac Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3496
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Virbac Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Virbac Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Virbac Corporation (Virbac or ‘the company’), a subsidiary of Virbac SA, is engaged in the manufacturing and marketing of animal health and pet care products. Virbac offers products for antibiotics, behavior, dental, dermatology, digestive, hormone, antibiotics, parasiticides, supplements and urinary. Under Anxitane, Novifit, C.e.t, Hextra, Orastrip, Veggiedent, Allergroom brands among others. The company primarily operates in the US where it is headquartered in Fort Worth, Texas, the US.

Scope

- Detailed information on Virbac Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Virbac Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Virbac Corporation including a breakdown and examination of key business segments
- Intelligence on Virbac Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Virbac Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Virbac Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Virbac Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Virbac Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Virbac Corporation: Company Overview
Virbac Corporation: Overview and Key Facts
Virbac Corporation: Overview
Virbac Corporation: Key Facts
Virbac Corporation: Key Employees
Virbac Corporation: Key Employee Biographies
Virbac Corporation: Major Products and Services
Virbac Corporation: Company History
Virbac Corporation: Management Statement
Virbac Corporation: Locations and Subsidiaries
Virbac Corporation: Key Competitors
Virbac Corporation: Company Analysis
Virbac Corporation: Business Description
Virbac Corporation: SWOT Analysis
Virbac Corporation: SWOT Overview
Virbac Corporation: Strengths
Virbac Corporation: Weaknesses
Virbac Corporation: Opportunities
Virbac Corporation: Threats
Virbac Corporation: Corporate Financial Deals Activity
Virbac Corporation: Financial Deals Overview
Virbac Corporation: Top Deals 2015 – 2019YTD*
Virbac Corporation: Divestments
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Virbac Corporation: Key Facts
Table 2: Virbac Corporation: Key Employees
Table 3: Virbac Corporation: Company History
Table 4: Virbac Corporation: Locations and Subsidiaries
Table 5: Virbac Corporation: Key Competitors
Table 6: Virbac Corporation: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Virbac Corporation: Top Deals 2015 - 2019YTD*
Table 8: Virbac Corporation: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[Virbac Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ergon Inc:企業の戦略的SWOT分析
    Ergon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • CSB Bancorp Inc (CSBB):企業の財務・戦略的SWOT分析
    CSB Bancorp Inc (CSBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Merck KGaA (MRK):医療機器:M&Aディール及び事業提携情報
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • Agfa-Gevaert NV (AGFB):企業の財務・戦略的SWOT分析
    Agfa-Gevaert NV (AGFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bri-Chem Corp. (BRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • Astellas Pharma Europe Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Astellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a manufacturer and distributor of drug products. The company provides pharmaceutical drugs in the areas of oncology, transplantation, urology, anti-infective, pain management and dermatology. It also provide …
  • Oceaneering International Inc (OII):企業の財務・戦略的SWOT分析
    Oceaneering International Inc (OII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Camber Energy Inc (CEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Camber Energy Inc (Camber Energy), formerly known as Lucas Energy, Inc., is an independent oil and gas company. It explores, develops, and produces crude oil, natural gas and natural gas liquids (NGL). The company has asset base in Texas and Oklahoma. Its producing fields include Lincoln, Lo …
  • Global Imaging Systems, Inc.:企業のM&A・事業提携・投資動向
    Global Imaging Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Imaging Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Explaurum Ltd (EXU):企業の財務・戦略的SWOT分析
    Summary Explaurum Ltd (Explaurum) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of precious and base metals deposits. It explores for copper, gold, silver, zinc, molybdenum, lead, tin, phosphates, aluminium, uranium and …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Acerinox Group:企業の戦略・SWOT・財務情報
    Acerinox Group - Strategy, SWOT and Corporate Finance Report Summary Acerinox Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Jordan International Insurance Company (JIJC):企業の財務・戦略的SWOT分析
    Jordan International Insurance Company (JIJC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Christian Dior SE:戦略・SWOT・企業財務分析
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kone Corporation:企業の戦略・SWOT・財務分析
    Kone Corporation - Strategy, SWOT and Corporate Finance Report Summary Kone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆